Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing


Lewis, Joseph M ORCID: 0000-0002-3837-5188, Railton, Eimear, Riordan, Andrew, Khoo, Saye ORCID: 0000-0002-2769-0967 and Chaponda, Mas (2016) Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing. AIDS, 30 (8). pp. 1313-1315.

[img] Text
Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing.pdf - Published version
Download (165kB)
Item Type: Article
Uncontrolled Keywords: Fetal Blood, Humans, Pregnancy Complications, Infectious, HIV Infections, Prenatal Exposure Delayed Effects, Oxazines, Piperazines, Pyridones, Heterocyclic Compounds, 3-Ring, HIV Integrase Inhibitors, Pregnancy Outcome, Pregnancy, Maternal-Fetal Exchange, Dose-Response Relationship, Drug, Adult, Infant, Newborn, Guideline Adherence, Female, Young Adult
Depositing User: Symplectic Admin
Date Deposited: 25 Apr 2017 06:16
Last Modified: 14 Mar 2024 18:01
DOI: 10.1097/QAD.0000000000001055
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3006825
Dimensions
Altmetric
CORE (COnnecting REpositories)